|
Below is an in-depth analysis and side-by-side comparison of HealthSource Chiropractic vs Baxter International including start-up costs and fees, business experience requirements, training & support and financing options.
Start-Up Costs and Fees |
||
Investment | $28,516 - $374,028 | $54,450 - $67,450 |
Franchise Fee | $30,000 - $45,000 | $20,000 |
Royalty Fee | 7%-9% | 5% |
Advertising Fee | 2% | - |
Year Founded | 1998 | - |
Year Franchised | 2006 | - |
Term Of Agreement | - | - |
Term Of Agreement | - | - |
Renewal Fee | - | - |
Business Experience Requirements |
||
Experience | - | - |
Financing Options |
||
In-House/3rd Party | In-House/3rd Party | |
Franchise Fees | -/- | -/- |
Start-up Costs | -/- | -/- |
Equipment | -/- | -/- |
Inventory | -/- | -/- |
Receivables | -/- | -/- |
Payroll | -/- | -/- |
Training & Support |
||
Training | - | - |
Support | - | - |
Marketing | - | - |
Operations | - | - |
Expansion Plans |
||
US Expansion | - | - |
Canada Expansion | - | - |
International Expansion | - | - |
Our mission is to serve the public by providing exceptional service within our professional scope of practice, and to deliver chiropractic care as a complementary adjunct to other treating physicians and health care providers. We utilize research supported techniques and modalities in an evidenced based protocol for care. We take measure to stay current in research, practice related journals, and professional papers. It is our sincere desire to be a significant resource for you, your office, and your client base.
Baxter gives an expansive arrangement of fundamental renal and clinic items, including home, intense and in-focus dialysis; clean IV arrangements; implantation frameworks and gadgets; parenteral sustenance; biosurgery items and sedatives; and drug store mechanization, programming and administrations. The organization's worldwide impression and the basic way of its items and administrations assume a key part in growing access to medicinal services in rising and created nations. Baxter's representatives worldwide are expanding upon the organization's rich legacy of therapeutic leaps forward to propel the up and coming era of social insurance developments that empower tolerant care.